ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

MELD -Na 15 and Lower – Way to Go Forward- DCD Liver Transplant or Wait for a Higher MELD Score ?

V. Vetrivel Venkatasamy1, P. Abreu1, J. Riella2, R. Shah3, R. Miyashiro2, G. Selvaggi3, A. Tekin2, R. Vianna3

1Department of Surgery, Division of Liver and GI Transplantation, University of Miami, Miami, FL, 2University of Miami, Miami, FL, 3University of Miami/Jackson Memorial Hospital, Miami, FL

Meeting: 2022 American Transplant Congress

Abstract number: 897

Keywords: Donors, non-heart-beating

Topic: Clinical Science » Liver » 59 - Liver: Expanding the Donor Pool* (Liver: MELD Allocation / Donor Issues)

Session Information

Session Name: Liver: Expanding the Donor Pool* (Liver: MELD Allocation / Donor Issues)

Session Type: Poster Abstract

Date: Saturday, June 4, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 5:30pm-7:00pm

Location: Hynes Halls C & D

*Purpose: Liver transplantation following donation after cardiac death (DCD) continues to be a subject for heated debate, bigger controversy is if MELD score of 15 not sick enough for DCD liver transplant. Whereas OPTN data shows 47.1 % of listed patients with MELD -Na less than 15 at time of listing. We analyzed data of DCD donors for LT in order to identify risk factors for graft and patient survival.

*Methods: This was a retrospective cohort study using data reviewed by screening SRTR/UNOS of patients that underwent liver transplantation with DCD donor at Jackson Memorial Hospital in Miami, FL from 2017 to 2021. Different surrogates were analyzed, including donor, recipient, procurement and transplant operation characteristics. The primary outcome was patient and graft survival. Continuous variables were analyzed using a 2-sided student t-test. Categorical variables were presented as frequencies and proportion and compared using chi-squared or Fisher’s exact test as appropriate. Univariable Cox proportional hazards models were fit in order to assess the impact of individual covariables on the instantaneous rate of events, with time-to-event analysis also being ascertained through Kaplan-Meier estimates.

*Results: 54 cases were analyzed, liver only transplants, excluding SLKs .Alcoholic cirrhosis was the most prevalent etiology for liver disease. The 1-year survival rate following liver transplant using DCD donors was 90.7% (Figure 1). If separated by MELD score at the time of transplant, results showed a survival of 100% (15 patients) with MELD < 15 and 87% (39 patients) with MELD ≥ 15 (Figure 2). Furthermore, the subset of patients with a history of hepatocellular carcinoma (HCC) had also 100% survival at 12-month follow-up vs. 87% when compared with patients without the diagnosis of HCC.

*Conclusions: DCD donors are excellent options to increase the availability of organs for patients waiting for a LT. With close to 50% of the waitlist dominated by patient with MELD lower than 15 , successful use of DCD livers with 100 % patient survival is the way forward in future thereby , reducing the waitlist mortality and morbidity due to decompensations and prevent wait list drop outs .

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Venkatasamy VVetrivel, Abreu P, Riella J, Shah R, Miyashiro R, Selvaggi G, Tekin A, Vianna R. MELD -Na 15 and Lower – Way to Go Forward- DCD Liver Transplant or Wait for a Higher MELD Score ? [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/meld-na-15-and-lower-way-to-go-forward-dcd-liver-transplant-or-wait-for-a-higher-meld-score/. Accessed May 26, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences